Related Experiment Video
Updated: May 19, 2026

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
Published on: October 13, 2023
The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual
Jai Radhakrishnan1, Daniel C Cattran
1Division of Nephrology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, New York 100321, USA. jr55@columbia.edu
Insights
The KDIGO guideline for glomerulonephritis aids healthcare providers in treating glomerular diseases. Individualized patient care requires clinical judgment beyond guideline evidence.
Area of Science:
- Nephrology
- Internal Medicine
- Clinical Practice Guidelines
Background:
- Glomerular diseases require expert management, with guidelines offering evidence-based support.
- Existing guidelines provide a framework but may not cover all clinical nuances.
- Variability in study strength complicates direct guideline application to individual patients.
Purpose of the Study:
- To highlight the importance of clinical judgment in applying the KDIGO guideline for glomerulonephritis.
- To illustrate how to individualize treatment plans for patients with glomerular diseases.
- To emphasize the integration of patient preferences and clinical acumen with evidence-based care.
Main Methods:
- Review of the KDIGO guideline for glomerulonephritis.
- Inclusion of clinical vignettes with specific features to demonstrate application challenges.
- Emphasis on case-based learning to foster clinical decision-making.
Main Results:
- Guidelines offer general recommendations, necessitating adaptation to individual patient circumstances.
- Clinical scenarios often require nuanced decision-making beyond strict guideline adherence.
- Case examples underscore the need for integrating evidence with clinical expertise and patient values.
Conclusions:
- Effective management of glomerulonephritis requires a blend of guideline recommendations and individualized clinical judgment.
- Healthcare providers must consider patient-specific factors, preferences, and clinical acumen for optimal outcomes.
- The KDIGO guideline serves as a valuable tool, but its application demands critical appraisal and personalization.
Abstract:
The KDIGO guideline for glomerulonephritis is designed to assist health-care providers in treating patients with glomerular diseases. A guideline is not a set of rules but is intended to allow the practitioner to make an informed decision based on the available evidence. Due to its general nature and the variability of strength of the available studies, it is often difficult to directly apply a guideline to the care of an individual patient. This commonly relates to the limited generalizability of the evidence, i.e., does not cover every clinical scenario. To underscore this point, we have introduced within the context of the glomerulonephritis guideline cases with specific features to illustrate the constant need for clinical judgment. These vignettes are intended to demonstrate how the best treatment plans should be individualized and take into account patient preference and clinical acumen, as well as the best available evidence.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
